# Effectiveness of Acetazolamide in Reducing Paralysis of the Leg in Patients Undergoing Aortic Aneurysm Surgery Surgery

Study · id `cardio:ct-nct01889498` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01889498](<https://clinicaltrials.gov/study/NCT01889498>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT01889498

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

## Technical summary

Registry record NCT01889498. Randomized; no masking; primary purpose treatment. Start 2014-07 (registry gives no type); primary completion 2016-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT01889498, source copy `cardio:ctgov-nct01889498-2014-12-31`, retrieved 2026-11-18)
- Start date: 2014-07 (registry gives no type) (ClinicalTrials.gov record NCT01889498, source copy `cardio:ctgov-nct01889498-2014-12-31`, retrieved 2026-11-18)
- Primary completion: 2016-06 (anticipated) (ClinicalTrials.gov record NCT01889498, source copy `cardio:ctgov-nct01889498-2014-12-31`, retrieved 2026-11-18)
- Completion: 2016-06 (anticipated) (ClinicalTrials.gov record NCT01889498, source copy `cardio:ctgov-nct01889498-2014-12-31`, retrieved 2026-11-18)
- Countries: United Kingdom (ClinicalTrials.gov record NCT01889498, source copy `cardio:ctgov-nct01889498-2014-12-31`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01889498-2014-12-31`, retrieved 2026-11-18)

## The registry's words

- Brief title: Effectiveness of Acetazolamide in Reducing Paralysis of the Leg in Patients Undergoing Aortic Aneurysm Surgery Surgery
- Acronym: AZATAAR
- Condition: Thoracic Aneurysm
- Intervention (Drug): Acetazolamide
- Lead sponsor: Liverpool Heart and Chest Hospital NHS Foundation Trust
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic aneurysm (`cardio:aortic-aneurysm`)
- Registry condition terms include this condition: Thoracic aortic aneurysm (`cardio:thoracic-aortic-aneurysm`)
- Registry lists this organization as the lead sponsor: Liverpool Heart and Chest Hospital NHS Foundation Trust (`cardio:org-liverpool-heart-and-chest-hospital-nhs-foundation-trust`)

## Provenance

Content hash: b341154ad60a422856c68e4928c684b72cd53a42d9d7d119f4f9c10f670ab03d
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
